Výsledky vyhledávání - "Sheila Prindiville"

Screening for Lung Cancer Revisited and the Role of Sputum Cytology and Fluorescence Bronchoscopy in a High-Risk Group

Autor: Sheila Prindiville, York E. Miller, Timothy C. Kennedy

Publikováno v: Chest. 117:72S-79S

Lung cancer is an epidemic disease that is underrepresented in the research funding for early detection and chemoprevention arenas. Screening programs have been discouraged for both financial and political reasons. Yet, increasing evidence suggests t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17d754ee3e7ec4b334c046671aedc0fa
https://doi.org/10.1378/chest.117.4_suppl_1.72s

Zobrazit plný text záznamu

Lack of association between sputum atypia and chronic obstructive pulmonary disease mortality

Autor: York E, Miller, Kieu O, Vu, Tim C, Kennedy, Fred R, Hirsch, Thomas L, Petty, Paul A, Bunn, Robert L, Keith, Wilbur A, Franklin, Holly J, Wolf, Sheila, Prindiville, Tim, Byers

Publikováno v: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 1(4)

Chronic obstructive pulmonary disease (COPD) and lung cancer are thought to share common elements in pathogenesis. The authors hypothesized that sputum atypia would reflect the processes leading to progressive airflow obstruction and might be a novel

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::829d9c4605e355dd8095aa8ed0c4ed3d
https://pubmed.ncbi.nlm.nih.gov/17409874

Zobrazit plný text záznamu

Hormone Replacement Therapy After Breast Cancer: How Shall We DoNo Harm?

Autor: Lisa Cyran, Sheila Prindiville, Tim Byers, Karlotta Davis

Publikováno v: Cancer Practice. 6:296-298

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b96cfe15fadc289ea87828a893c1c6ac
https://doi.org/10.1046/j.1523-5394.1998.00026.x

Zobrazit plný text záznamu

Pilot trial of the safety, tolerability, and retinoid levels of N-(4-hydroxyphenyl) retinamide in combination with tamoxifen in patients at high risk for developing invasive breast cancer

Autor: Marvin Podgor, Sheila Prindiville, David Danforth, Barry Goldspiel, Elizabeth Jones, Jennifer Goldstein, David Venzon, Catherine Chow, Kenneth H. Cowan, Barbara A. Conley, Jo Anne Zujewski, Julia Lawrence, Rafael C. Caruso, Joyce O'Shaughnessy, Muriel I. Kaiser-Kupfer, Marianne Noone, Suhlan Wu, Maria J. Merino

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 18(2)

PURPOSE: N-(4-hydroxyphenyl) retinamide ([4-HPR], Fenretinide; R.W. Johnson Pharmaceutical Research Institute, Springhouse, PA) and tamoxifen (TAM) have synergistic antitumor and chemopreventive activity against mammary cancer in preclinical studies.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd34fec70221e7d1771b531d882c4226
https://pubmed.ncbi.nlm.nih.gov/10637240

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání